Functional analysis of the genetic variability in the F7 gene promoter

Maria Sabater-Lleal, Miguel Chillón, Tom E. Howard, Estel Gil, Laura Almasy, John Blangero, Jordi Fontcuberta, José Manuel Soria

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The FVII level is considered a risk factor for cardiovascular disease. Some of the polymorphic differences in the promoter of the F7 gene have been associated with variations in FVII levels. However, linkage disequilibrium among those polymorphisms has made it difficult to pinpoint the true functional variants, so contradictory results have often appeared among various studies. We provide new findings of the effect of the polymorphisms in the promoter region of F7. In vitro transfection of 15 plasmids containing different combinations of F7 promoter polymorphisms was performed in HepG2 cells. We found that allelic variants -323ins10 and -122C strongly reduced promoter activity and that allelic variant -402A significantly increased promoter activity. We report the effect of a novel variant (-2989A) that significantly increases F7 expression levels. However, this novel allelic variant is in strong linkage disequilibrium with the -323ins10 variant in our Spanish population, which has a clear dominant effect over the -2989A variant and completely masks its effect. Our results have important implications for mapping genes affecting complex diseases using association studies. That is, they imply that true functional variants should be chosen to confirm the analyses and to ensure that the results can be reproduced in other populations. In addition, our results suggest that it would be informative to screen for the -2989A variant in other populations, since it may well be a risk factor for cardiovascular disease in populations where it does not appear with the decanucleotide insertion.

Original languageEnglish (US)
Pages (from-to)262-268
Number of pages7
JournalAtherosclerosis
Volume195
Issue number2
DOIs
StatePublished - Dec 2007
Externally publishedYes

Fingerprint

Linkage Disequilibrium
Population
Genes
Cardiovascular Diseases
Chromosome Mapping
Hep G2 Cells
Masks
Genetic Promoter Regions
Transfection
Plasmids
In Vitro Techniques

Keywords

  • F7
  • Functional analyses
  • FVII
  • Promoter expression

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Sabater-Lleal, M., Chillón, M., Howard, T. E., Gil, E., Almasy, L., Blangero, J., ... Soria, J. M. (2007). Functional analysis of the genetic variability in the F7 gene promoter. Atherosclerosis, 195(2), 262-268. https://doi.org/10.1016/j.atherosclerosis.2006.12.031

Functional analysis of the genetic variability in the F7 gene promoter. / Sabater-Lleal, Maria; Chillón, Miguel; Howard, Tom E.; Gil, Estel; Almasy, Laura; Blangero, John; Fontcuberta, Jordi; Soria, José Manuel.

In: Atherosclerosis, Vol. 195, No. 2, 12.2007, p. 262-268.

Research output: Contribution to journalArticle

Sabater-Lleal, M, Chillón, M, Howard, TE, Gil, E, Almasy, L, Blangero, J, Fontcuberta, J & Soria, JM 2007, 'Functional analysis of the genetic variability in the F7 gene promoter', Atherosclerosis, vol. 195, no. 2, pp. 262-268. https://doi.org/10.1016/j.atherosclerosis.2006.12.031
Sabater-Lleal M, Chillón M, Howard TE, Gil E, Almasy L, Blangero J et al. Functional analysis of the genetic variability in the F7 gene promoter. Atherosclerosis. 2007 Dec;195(2):262-268. https://doi.org/10.1016/j.atherosclerosis.2006.12.031
Sabater-Lleal, Maria ; Chillón, Miguel ; Howard, Tom E. ; Gil, Estel ; Almasy, Laura ; Blangero, John ; Fontcuberta, Jordi ; Soria, José Manuel. / Functional analysis of the genetic variability in the F7 gene promoter. In: Atherosclerosis. 2007 ; Vol. 195, No. 2. pp. 262-268.
@article{0777718cf63348c8bf7d4fc568c79c86,
title = "Functional analysis of the genetic variability in the F7 gene promoter",
abstract = "The FVII level is considered a risk factor for cardiovascular disease. Some of the polymorphic differences in the promoter of the F7 gene have been associated with variations in FVII levels. However, linkage disequilibrium among those polymorphisms has made it difficult to pinpoint the true functional variants, so contradictory results have often appeared among various studies. We provide new findings of the effect of the polymorphisms in the promoter region of F7. In vitro transfection of 15 plasmids containing different combinations of F7 promoter polymorphisms was performed in HepG2 cells. We found that allelic variants -323ins10 and -122C strongly reduced promoter activity and that allelic variant -402A significantly increased promoter activity. We report the effect of a novel variant (-2989A) that significantly increases F7 expression levels. However, this novel allelic variant is in strong linkage disequilibrium with the -323ins10 variant in our Spanish population, which has a clear dominant effect over the -2989A variant and completely masks its effect. Our results have important implications for mapping genes affecting complex diseases using association studies. That is, they imply that true functional variants should be chosen to confirm the analyses and to ensure that the results can be reproduced in other populations. In addition, our results suggest that it would be informative to screen for the -2989A variant in other populations, since it may well be a risk factor for cardiovascular disease in populations where it does not appear with the decanucleotide insertion.",
keywords = "F7, Functional analyses, FVII, Promoter expression",
author = "Maria Sabater-Lleal and Miguel Chill{\'o}n and Howard, {Tom E.} and Estel Gil and Laura Almasy and John Blangero and Jordi Fontcuberta and Soria, {Jos{\'e} Manuel}",
year = "2007",
month = "12",
doi = "10.1016/j.atherosclerosis.2006.12.031",
language = "English (US)",
volume = "195",
pages = "262--268",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Functional analysis of the genetic variability in the F7 gene promoter

AU - Sabater-Lleal, Maria

AU - Chillón, Miguel

AU - Howard, Tom E.

AU - Gil, Estel

AU - Almasy, Laura

AU - Blangero, John

AU - Fontcuberta, Jordi

AU - Soria, José Manuel

PY - 2007/12

Y1 - 2007/12

N2 - The FVII level is considered a risk factor for cardiovascular disease. Some of the polymorphic differences in the promoter of the F7 gene have been associated with variations in FVII levels. However, linkage disequilibrium among those polymorphisms has made it difficult to pinpoint the true functional variants, so contradictory results have often appeared among various studies. We provide new findings of the effect of the polymorphisms in the promoter region of F7. In vitro transfection of 15 plasmids containing different combinations of F7 promoter polymorphisms was performed in HepG2 cells. We found that allelic variants -323ins10 and -122C strongly reduced promoter activity and that allelic variant -402A significantly increased promoter activity. We report the effect of a novel variant (-2989A) that significantly increases F7 expression levels. However, this novel allelic variant is in strong linkage disequilibrium with the -323ins10 variant in our Spanish population, which has a clear dominant effect over the -2989A variant and completely masks its effect. Our results have important implications for mapping genes affecting complex diseases using association studies. That is, they imply that true functional variants should be chosen to confirm the analyses and to ensure that the results can be reproduced in other populations. In addition, our results suggest that it would be informative to screen for the -2989A variant in other populations, since it may well be a risk factor for cardiovascular disease in populations where it does not appear with the decanucleotide insertion.

AB - The FVII level is considered a risk factor for cardiovascular disease. Some of the polymorphic differences in the promoter of the F7 gene have been associated with variations in FVII levels. However, linkage disequilibrium among those polymorphisms has made it difficult to pinpoint the true functional variants, so contradictory results have often appeared among various studies. We provide new findings of the effect of the polymorphisms in the promoter region of F7. In vitro transfection of 15 plasmids containing different combinations of F7 promoter polymorphisms was performed in HepG2 cells. We found that allelic variants -323ins10 and -122C strongly reduced promoter activity and that allelic variant -402A significantly increased promoter activity. We report the effect of a novel variant (-2989A) that significantly increases F7 expression levels. However, this novel allelic variant is in strong linkage disequilibrium with the -323ins10 variant in our Spanish population, which has a clear dominant effect over the -2989A variant and completely masks its effect. Our results have important implications for mapping genes affecting complex diseases using association studies. That is, they imply that true functional variants should be chosen to confirm the analyses and to ensure that the results can be reproduced in other populations. In addition, our results suggest that it would be informative to screen for the -2989A variant in other populations, since it may well be a risk factor for cardiovascular disease in populations where it does not appear with the decanucleotide insertion.

KW - F7

KW - Functional analyses

KW - FVII

KW - Promoter expression

UR - http://www.scopus.com/inward/record.url?scp=34250695026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250695026&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2006.12.031

DO - 10.1016/j.atherosclerosis.2006.12.031

M3 - Article

C2 - 17292373

AN - SCOPUS:34250695026

VL - 195

SP - 262

EP - 268

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2

ER -